The Institute for Continuing Healthcare Education

DermInsider - Session 1

MD, MAS

small_hero 211.png

thumbnail_hero 211.png

hero 211.png

Discuss the multifactorial rationale for combining interleukin (IL)-17 inhibitors with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in psoriatic disease management

Examine clinical data related to the combination of biologic therapies with GLP-1RAs in psoriatic disease management for overweight or obese patients

Describe patient selection considerations when choosing combination biologic/GLP-1RA regimens for psoriatic disease management

large_mini 211.png

medium_mini 211.png

small_mini 211.png

thumbnail_mini 211.png

mini 211.png

Psoriasis

2026 DermInsider

Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science 

DermInsider - Session 1: Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science

DermInsider - Session 1: Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures